CoQ10 Biomarker Trial

NACompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

October 31, 2013

Study Completion Date

December 31, 2013

Conditions
Oxidative StressInflammationEndothelial Dysfunction
Interventions
DIETARY_SUPPLEMENT

Coenzyme Q10

Wafer taken daily by mouth for duration of study, containing Coenzyme Q10 at 600 mg.

DIETARY_SUPPLEMENT

Coenzyme Q10

Wafer taken daily by mouth for duration of study, containing Coenzyme Q10 at 1200 mg.

DIETARY_SUPPLEMENT

Placebo

Wafer taken daily by mouth for duration of study, containing inactive ingredients. Wafer is indistinguishable from those wafers containing CoQ10.

Trial Locations (1)

98122

Northwest Kidney Centers, Seattle

All Listed Sponsors
collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

lead

University of Washington

OTHER

NCT01408680 - CoQ10 Biomarker Trial | Biotech Hunter | Biotech Hunter